-transparent.png){kind=logo}
Myostatin, a new TGF-beta family member, is known as a muscle growth inhibitor, but its role in adipocyte development has not been studied. To test the role of Myostatin in 3T3-L1 preadipocyte differentiation, we treated cultured 3T3-L1 preadipocytes with Myostatin dissolved in 0.1% trifluoroacetic acid (TFA) during differentiation after they had become confluent. Myostatin treatment significantly decreased glycerol-3-phosphate dehydrogenase (GPDH) activity and oil Red-O staining compared to controls that did not receive Myostatin. Western blot analysis showed that the expression levels of CCAAT/enhancer binding protein alpha (C/EBP alpha) and peroxisome proliferator-activated receptor gamma (PPAR gamma) were significantly decreased by Myostatin treatment (P < 0.05). However, the expression of C/EBP beta was not significantly changed by the treatment (P > 0.05). From RT-PCR result, the relative level of leptin mRNA in Myostatin-treated cells was not significantly different (P > 0.1) from the level in cells without Myostatin treatment. Our data show that Myostatin, a secreted protein from muscle, inhibits preadipocyte differentiation in 3T3-L1 cells, which is mediated, in part, by altered regulation of C/EBP alpha and PPAR gamma.
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
January 2012,
Phytotherapy research : PTR,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
December 2002,
Tissue engineering,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
December 1996,
Endocrinology,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
May 2013,
Journal of diabetes investigation,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
June 2004,
European journal of endocrinology,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
November 2015,
Experimental biology and medicine (Maywood, N.J.),
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
December 2005,
Bioscience, biotechnology, and biochemistry,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
March 2005,
Molecular and cellular endocrinology,
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
June 2016,
Molecular endocrinology (Baltimore, Md.),
H S Kim, and
L Liang, and
R G Dean, and
D B Hausman, and
D L Hartzell, and
C A Baile
June 2007,
Molecular and cellular biochemistry,
